| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |